Vitamin D Research

back to research menu

Mortality

Featured Studies: All-cause Mortality

• Serum concentrations of 17beta-E and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men—the MINOS study. Clin Endocrinol (Oxf). 2009 Oct;71(4):594–602.
• Parathyroid Hormone as a Mortality Predictor in Frail Aged Inpatients. Gerontology. 2009 Sep 15.
• Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality? Intensive Care Med. 2009 Sep 15.
• Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med. 2009 Sep;122(9):793–802. Review.
• Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol. 2009 Sep;4(9):1515–22.
• Nutrition and health: guidelines for dental practitioners. Oral Dis. 2009 Sep;15(6):369–81.
• Vitamin D: In the evolution of human skin colour. Med Hypotheses. 2009 Aug 28.
• Vitamin D deficiency and mortality. Curr Opin Clin Nutr Metab Care. 2009 Aug 25.
• Is Vitamin D the Fountain of Youth? Endocr Pract. 2009 Jun 2:1–25.
• Circulating calcitriol concentrations and total mortality. Clin Chem. 2009 Jun;55(6):1163–70.
• The impact of lifestyle factors on serum 25-hydroxyvitamin D levels: a cross-sectional study in Japanese women aged 19–25 years. J Bone Miner Metab. 2009 May 14.
• Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Bone Miner Res. 2009 May 6.
• Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf). 2009 Feb 18.
• Vitamin D and human health. Presse Med. 2009 Jan;38(1):3–6.
• Vitamin D: skeletal and extra skeletal effects; recommendations for good practice. Presse Med. 2009 Jan;38(1):43–54. Review.
• Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women. Bone. 2009 Jan;44(1):168–72.
• Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr Cancer. 2009;61(2):225–31.
• Dietary supplement use and mortality in a cohort of Swedish men—comments by Boucher. Br J Nutr. 2008 Dec;100(6):1345; discussion 1346.
• The contribution of diet and sun exposure to the nutritional status of vitamin D in elderly Spanish women: the five countries study (OPTIFORD Project). Nutr Hosp. 2008 Nov–Dec;23(6):567–76.
• 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008 Aug 11;168(15):1629–37.
• Active vitamin D and survival. J Am Soc Nephrol. 2008 Aug;19(8):1442–3.
• Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008 Jun 23;168(12):1340–9.
• Estimating the global disease burden due to ultraviolet radiation exposure. Int J Epidemiol. 2008 Jun;37(3):654–67.
• Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. Eur J Endocrinol. 2008 May;158(5):749–53.
• Review: vitamin D supplementation decreases all-cause mortality in adults and older people. Evid Based Med. 2008 Apr;13(2):47.
• Review: vitamin D supplementation decreases all-cause mortality in adults and older individuals. ACP J Club. 2008 Mar–Apr;148(2):30.
• Use of vitamin D in clinical practice. Altern Med Rev. 2008 Mar;13(1):6–20. Review.
• Hypovitaminosis D among 18-to-49-years-old women wearing concealing clothes, an ignored reality in general practice. Presse Med. 2008 Feb;37(2 Pt 1):201–6.
• Nutritional considerations in institutionalized elders. Curr Opin Clin Nutr Metab Care. 2008 Jan;11(1):1–6. Review.
• Vitamin D supplements could add years to life. Lower your risk of death by seven percent with a daily dose of vitamin D. Health News. 2008 Jan;14(1):9–10.
• Elevated plasma gamma-tocopherol and decreased alpha-tocopherol in men are associated with inflammatory markers and decreased plasma 25-OH vitamin D. Nutr Cancer. 2008;60 Suppl 1:21–9.
• Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007 Sep 10;167(16):1730–7. Review.
• Can vitamin D reduce total mortality? Arch Intern Med. 2007 Sep 10;167(16):1709–10.
• Emerging therapies to treat frailty syndrome in the elderly. Altern Med Rev. 2007 Sep;12(3):246–58.
• Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J Nutr. 2007 Sep;98(3):593–9.
• Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Ann Clin Lab Sci. 2007 Summer;37(3):222–32.
• Anthropometric and biochemical markers for nutritional risk among residents within an Australian residential care facility. Asia Pac J Clin Nutr. 2007;16(1):178–86.
• Comparison of rocket and crossed immuno-electrophoresis assays for determination of the level of actin complexing of Gc globulin. Scand J Clin Lab Invest. 2007;67(7):767–77.
• Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr. 2006 Sep;84(3):616–22; quiz 671–2.
• Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Sep;92(1):65–79.
• Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clin Endocrinol (Oxf). 2008 Feb;68(2):290–8.
• The 25-hydroxyvitamin D threshold for better health. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):614–9.
• Anthropometric and biochemical markers for nutritional risk among residents within an Australian residential care facility. Asia Pac J Clin Nutr. 2007;16(1):178–86.
• Repeated assessment of energy and nutrient intake in 52 nursing home residents. J Nutr Health Aging. 2006 May–Jun;10(3):222–30.
• Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem Photobiol. 2005 Nov–Dec;81(6):1276–86.
• Health disparities: reframing the problem. Med Sci Monit. 2003 Mar;9(3):SR9–15. Review.
• Identification of wrong or inadequate nutrition of elderly patients in an acute-admissions hospital. Dtsch Med Wochenschr. 2003 Feb 28;128(9):425–8.
• Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists. Med Hypotheses. 2001 Aug;57(2):258–75.
• Commentary on the Women's Health Initiative. Maturitas. 2000 Feb 15;34(2):109–12.
• Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998 Feb;19(1):61–109.
• Healthy aging. A women's issue. West J Med. 1997 Oct;167(4):220–32. Review.
• Multiple sclerosis and prostate cancer: what do their similar geographies suggest? Neuroepidemiology. 1992;11(4–6):244–54.
• Aging and calcium as an environmental factor. J Nutr Sci Vitaminol (Tokyo). 1985 Dec;31 Suppl:S15–9.

Infant Mortality

• Perinatal Outcomes, Including Mother-to-Child Transmission of HIV, and Child Mortality and Their Association with Maternal Vitamin D Status in Tanzania. J Infect Dis. 2009 Oct 1;200(7):1022–30.
• Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections? Schizophr Bull. 2009 May;35(3):582–95.
• Hypocalcemic tetany in the newborn as a manifestation of unrecognized maternal primary hyperparathyroidism. Wien Klin Wochenschr. 2007;119(3–4):129–31.
• Necrotizing enterocolitis increases the bone resorption in premature infants. Early Hum Dev. 2006 Jun;82(6):405–9.
• Nutritional management of multiple pregnancies. Twin Res. 2003 Dec;6(6):514–9. Review.
• Vitamin A and sudden infant death syndrome in Scandinavia 1992–1995. Acta Paediatr. 2003;92(2):162–4.
• Primary hyperparathyroidism with persistent hypercalcemia in pregnancy. Gynakol Geburtshilfliche Rundsch. 2003 Jan;43(1):36–8.
• Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: variable expressivity of maternal illness during pregnancy and unusual presentation with infantile cholestasis and hypocalcaemia. J Inherit Metab Dis. 1999 Oct;22(7):811–4.
• Russia's population sink. World Watch. 1996 Jan–Feb;9(1):22–3.
• Infant feeding and growth of Chinese infants: birth to 2 years. Paediatr Perinat Epidemiol. 1994 Jul;8(3):301–13.
• Myelofibrosis in severe combined immunodeficiency due to vitamin D deficiency rickets. Acta Haematol. 1994;92(3):160–3. Review.
• Seasonality of hip fracture and haemorrhagic disease of the newborn. Scott Med J. 1993 Apr;38(2):37–40.
• Neonatal convulsions: aetiology, late neonatal status and long-term outcome. Dev Med Child Neurol. 1978 Apr;20(2):143–8.
• Hypo- and hyperparathyroidism in pregnancy. Z Gesamte Inn Med. 1977 Mar 1;32(5):113–8. Review.
• Maternal anticonvulsants and perinatal risk. Eur J Obstet Gynecol Reprod Biol. 1975;5(5):277–82.
• Rickets as cause of death in infant and children? Med Klin. 1969 Mar 21;64(12):527–9.
• Effect of rickets prevention on bronchopneumonia morbidity and mortality in children during the 1st vear of life in rural areas. Pediatr Akus Ginekol. 1962;5:32–3.

Mortality Related to Specific Health Issues

Autoimmune Disease Mortality

• Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease'. Nutrition in Crohn's disease. Pancreas. 2009 May;38(4):387–90.
• The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep. 2008 Aug;10(4):273–80.

Cachexia-related Mortality

• Calories and cachexia. Curr Opin Clin Nutr Metab Care. 2009 Sep 7.

Cancer Mortality

• Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009 Oct 6.
• Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer. 2009 Sep 15;101(6):916–23.
• Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res. 2009 Sep;29(9):3699–704. Review.
• Calcium, vitamin D and cancer. Anticancer Res. 2009 Sep;29(9):3687–98. Review.
• Solar radiation, vitamin D and cancer incidence and mortality in Norway. Anticancer Res. 2009 Sep;29(9):3501–9. Review.
• Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev. 2009 Aug 26.
• Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol. 2009 Jul;19(7):446–54.
• Latitude variation in pancreatic cancer mortality in Australia. Pancreas. 2009 May;38(4):387–90.
• Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009 Apr 16.
• Vitamin D deficiency increases the risk of death from prostate cancer. Ugeskr Laeger. 2009 Apr 6;171(15):1303.
• Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia. Leukemia. 2009 Mar;23(3):545–56.
• Association between serum 25(OH)D and death from prostate cancer. Br J Cancer. 2009 Feb 10;100(3):450–4.
• A brief history of vitamin d and cancer prevention. Ann Epidemiol. 2009 Feb;19(2):79–83. Review.
• Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol. 2009 Feb;19(2):84–8. Review.
• Incident invasive breast cancer, geographic location of residence, and reported average time spent outside. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):495–507.
• Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis. 2009 Feb;24(2):219–24.
• Can the Mediterranean diet prevent prostate cancer? Mol Nutr Food Res. 2009 Feb;53(2):227–39. Review.
• Vitamin D and cancer mortality. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):359; author reply 359–60.
• Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients. Int J Cancer. 2008 Sep 15;123(6):1376–84.
• Differences in vitamin-D status may explain black-white differences in breast cancer survival rates. J Natl Med Assoc. 2008 Sep;100(9):1040.
• Prostate cancer survival: is there a dietary connection? Nutr Rev. 2008 Jul;66(7):425–6; author reply 427.
• Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008 Jun 20;26(18):2984–91.
• Shedding light on colorectal cancer prognosis: vitamin d and beyond. J Clin Oncol. 2008 Jun 20;26(18):2937–9.
• Re: Prospective study of vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2008 Jun 4;100(11):826.
• Re: Prospective study of vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2008 Jun 4;100(11):826–7.
• Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases. Histopathology. 2008 Jun;52(7):824–30.
• Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Int J Immunogenet. 2008 Jun;35(3):207–13.
• Shedding light on vitamin D and integrative oncology. Integr Cancer Ther. 2008 Jun;7(2):81–9.
• Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1228–33.
• Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer. Clin Cancer Res. 2008 Apr 15;14(8):2437–43.
• Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv Exp Med Biol. 2008;624:43–54.
• Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol. 2008;624:31–42. Review.
• Solar ultraviolet irradiance and cancer incidence and mortality. Adv Exp Med Biol. 2008;624:16–30. Review.
• Bone mass density, subsequent risk of colon cancer and survival in postmenopausal women. Eur J Epidemiol. 2008;23(7):467–73.
• Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia. Oncology. 2008;75(3–4):203–14.
• Colon cancer: prognosis for different latitudes, age groups and seasons in Norway. J Photochem Photobiol B. 2007 Dec 14;89(2–3):148–55.
• Epidemiological evidence for vitamin D and colorectal cancer. J Bone Miner Res. 2007 Dec;22 Suppl 2:V81–5. Review.
• 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol. 2007 Dec;85(3):255–62.
• Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2007 Nov 7;99(21):1594–602.
• Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2193–203. Review.
• Vitamin D and cancer. J Cancer Res Ther. 2007 Oct–Dec;3(4):225–30. Review.
• Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma. J Urol. 2007 Oct;178(4 Pt 1):1497–503.
• Prostate cancer survival is dependent on season of diagnosis. Prostate. 2007 Sep 1;67(12):1362–70.
• Solar elastosis in cutaneous melanoma. Am J Clin Pathol. 2007 Aug;128(2):260–4.
• Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series. Mod Pathol. 2007 Jul;20(7):760–9.
• Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population. Int J Urol. 2007 Jun;14(6):483–7.
• Molecular epidemiology of prostate cancer: hormone-related genetic loci. Front Biosci. 2007 May 1;12:3436–60. Review.
• Vitamin D and breast cancer. Ugeskr Laeger. 2007 Apr 2;169(14):1299–302. Review.
• Does solar ultraviolet irradiation affect cancer mortality rates in China? Asian Pac J Cancer Prev. 2007 Apr–Jun;8(2):236–42.
• An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer. 2007 Mar 1;120(5):1123–8.
• Will the climate change affect the mortality from prostate cancer? Arch Esp Urol. 2007 Mar;60(2):119–23.
• Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):708–11.
• Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):675–8.
• Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer. 2007 Mar;55(3):263–70.
• Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol. 2007 Feb 10;25(5):479–85.
• Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population. Rev Invest Clin. 2007 Jan–Feb;59(1):25–31.
• An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day. Recent Results Cancer Res. 2007;174:225–34. Review.
• Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med. 2006 Dec;31(6):512–4.
• Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2467–72.
• Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002. BMC Cancer. 2006 Nov 10;6:264.
• Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2239–45.
• Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy. Int J Cancer. 2006 Oct 15;119(8):1902–7.
• UV, latitude, and spatial trends in prostate cancer mortality: all sunlight is not the same (United States). Cancer Causes Control. 2006 Oct;17(8):1091–101.
• Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer. 2006 Oct 1;119(7):1530–6.
• Does sunlight have a beneficial influence on certain cancers? Prog Biophys Mol Biol. 2006 Sep;92(1):132–9. Review.
• UV radiation and cancer prevention: what is the evidence? Anticancer Res. 2006 Jul–Aug;26(4A):2723–7. Review.
• The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res. 2006 Jul–Aug;26(4A):2687–99.
• The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survival. Anticancer Res. 2006 Jul–Aug;26(4A):2605–14.
• Vitamin D and cancer. Anticancer Res. 2006 Jul–Aug;26(4A):2515–24. Review.
• Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer. Cancer. 2006 May 15;106(10):2136–42.
• Vitamin D receptor is a novel drug target for ovarian cancer treatment. Curr Cancer Drug Targets. 2006 May;6(3):229–44. Review.
• Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006 Apr 5;98(7):451–9.
• Vitamin D status and cancer incidence and mortality: something new under the sun. J Natl Cancer Inst. 2006 Apr 5;98(7):428–30.
• Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Natl Med Assoc. 2006 Mar;98(3):357–64.
• The role of vitamin D in cancer prevention. Am J Public Health. 2006 Feb;96(2):252–61. Review.
• Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status. Cancer Biother Radiopharm. 2006 Feb;21(1):68–73.
• A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):203–10.
• Chemopreventive trials in urologic cancer. Rev Urol. 2006 Winter;8(1):8–13.
• Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D. Br J Cancer. 2005 Sep 5;93(5):571–4.
• ASCENT: the androgen-independent prostate cancer study of calcitriol enhancing taxotere. BJU Int. 2005 Sep;96(4):508–13.
• Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005 Aug 3;97(15):1158; author reply 1159–62.
• Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005 Aug 3;97(15):1158–9; author reply 1159–60.
• Effects of calcitriol, seocalcitol, and medium-chain triglyceride on a canine transitional cell carcinoma cell line. Anticancer Res. 2005 Jul–Aug;25(4):2689–96.
• Vitamin D and the epidemiology of prostate cancer. Semin Dial. 2005 Jul–Aug;18(4):276–89. Review.
• Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B. 2005 Mar 1;78(3):189–93.
• The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005 Mar;16(2):83–95. Review.
• Sunlight and reduced risk of cancer: is the real story vitamin D? J Natl Cancer Inst. 2005 Feb 2;97(3):161–3.
• Vitamin D receptor gene polymorphisms and disease free survival after radical prostatectomy. Prostate. 2004 Nov 1;61(3):267–75.
• Ecological study of solar radiation and cancer mortality in Japan. Health Phys. 2004 Nov;87(5):532–8.
• Geographic variation of prostate cancer mortality rates in the United States: Implications for prostate cancer risk related to vitamin D. Int J Cancer. 2004 Sep 1;111(3):470–1; author reply 472.
• Metastatic growth of lung cancer cells is extremely reduced in Vitamin D receptor knockout mice. J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):545–7.
• Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control. 2004 Mar;15(2):149–58.
• A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality. Eur Urol. 2004 Mar;45(3):271–9.
• Vitamin D and skin: new aspects for dermatology. Exp Dermatol. 2004;13 Suppl 4:11–5. Review.
• Mediterranean diet, micronutrients and prostate carcinoma: a rationale approach to primary prevention of prostate cancer. Arch Ital Urol Androl. 2003 Sep;75(3):166–78. Review.
• Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia. 2003 Jan–Feb;5(1):32–40.
• Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review). Int J Oncol. 2003 Jan;22(1):5–13. Review.
• Ecologic studies of solar UVB radiation and cancer mortality rates. Recent Results Cancer Res. 2003;164:371–7. Review.
• Calbindin-d(28k): a marker of recurrence for medulloblastomas. Cancer. 2002 Jul 15;95(2):410–9.
• Vitamin D and prostate cancer. J Androl. 2002 Jan–Feb;23(1):9–17. Review.
• An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer. 2002 Jan 1;94(1):272–81.
• Vitamin D-related therapies in prostate cancer. Cancer Metastasis Rev. 2002;21(2):147–58. Review.
• Clinical and pathological significance of vitamin D receptor gene polymorphism for prostate cancer which is associated with a higher mortality in Japanese. Endocr J. 2001 Oct;48(5):543–9.
• Prevention of prostate cancer. Hematol Oncol Clin North Am. 2001 Jun;15(3):445–57. Review.
• 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001 May 26;357(9269):1673–4.
• Prostate cancer prevention trials in the USA. Eur J Cancer. 2000 Jun;36(10):1312–5. Review.
• New Developments in the Therapy of Acute Myelocytic Leukemia. Hematology Am Soc Hematol Educ Program. 2000:69–89.
• Phosphorus balance and prostate cancer. Indian J Exp Biol. 1999 Jul;37(7):623–6. Review.
• Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res. 1999 May 15;59(10):2332–4.
• Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann N Y Acad Sci. 1999;889:107–19. Review.
• Vitamin D and prostate cancer risk. Eur Urol. 1999;35(5–6):392–4. Review.
• Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology. 1997 Dec;50(6):999–1006.
• Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31. J Steroid Biochem Mol Biol. 1996 Jun;58(3):277–88.
• Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol. 1994 Dec;23(6):1133–6.
• Beneficial effects of sun exposure on cancer mortality. Prev Med. 1993 Jan;22(1):132–40. Review.
• Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer. 1992 Dec 15;70(12):2861–9.
• Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr. 1991 Jul;54(1 Suppl):193S–201S. Review.
• Low-dose ARA-C and 1(OH) D3 administration in acute non lymphoid leukemia: pilot study. Haematologica. 1991 May–Jun;76(3):200–3.
• Sunlight and breast cancer incidence in the USSR. Int J Epidemiol. 1990 Dec;19(4):820–4.
• Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990 Nov;19(6):614–22.
• Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res. 1990 Sep–Oct;10(5A):1307–11.
• Acid haze air pollution and breast and colon cancer mortality in 20 Canadian cities. Can J Public Health. 1989 Mar–Apr;80(2):96–100.
• Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1985 Feb 9;1(8424):307–9.
• Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980 Sep;9(3):227–31.

Cardiovascular Mortality

• Vitamin D Status and the Risk of Cardiovascular Disease Death. Am J Epidemiol. 2009 Sep 17.
• Calcium supplementation, cardiovascular disease and mortality in older women. Pharmacoepidemiol Drug Saf. 2009 Sep 15.
• 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009 Aug;20(8):1805–12.
• Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009 Jun 2;119(21):2765–71.
• Paricalcitol and outcome: A manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U". Clin Nephrol. 2009 Jun;71(6):593–601.
• Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. Med Hypotheses. 2009 Jun;72(6):647–51.
• Vitamin D Deficiency and Its Correlations With Increased Cardiovascular Incidences. Am J Ther. 2009 May 15.
• Can moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias? Med Hypotheses. 2009 May;72(5):581–3.
• Nutrition and heart failure: impact of drug therapies and management strategies. Nutr Clin Pract. 2009 Feb–Mar;24(1):60–75. Review.
• Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation. 2009 Jan 15;87(1):118–24.
• Vitamin D and the vasculature: can we teach an old drug new tricks? Expert Opin Ther Targets. 2009 Jan;13(1):29–38. Review.
• Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients. Am J Clin Nutr. 2009 Jan;89(1):436; author reply 436–8.
• Cardiovascular Complications in Peritoneal Dialysis Patients. Contrib Nephrol. 2009;163:102–109.
• Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):752–7. Review.
• The seasonality in heart failure deaths and total cardiovascular deaths. Aust N Z J Public Health. 2008 Oct;32(5):408–13.
• The "sunshine deficit" and cardiovascular disease. Circulation. 2008 Sep 30;118(14):1476–85. Review.
• Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke. 2008 Sep;39(9):2611–3.
• Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro. Eur J Clin Invest. 2008 Aug;38(8):548–54.
• Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail. 2008 Mar;10(3):321–7.
• Arterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1alpha. Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2598–603.
• Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008 Jan;11(1):7–12. Review.
• Incident solar radiation and coronary heart disease mortality rates in Europe. Eur J Epidemiol. 2008;23(9):609–14. Review.
• Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells. Am J Physiol Renal Physiol. 2007 Nov;293(5):F1592–604.
• Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16810–5.
• Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol. 2007 Jul;18(7):2116–24.
• The potential for vitamin D receptor activation in cardiovascular research. Expert Opin Investig Drugs. 2007 Apr;16(4):407–11. Review.
• Vitamin D and vascular calcification. Curr Opin Lipidol. 2007 Feb;18(1):41–6. Review.
• Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006 Sep;92(1):39–48. Review.
• Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006 Apr;83(4):754–9.
• Calcific arteriolopathy (Calciphylaxis). Rev Med Interne. 2006 Mar;27(3):184–95. Review.
• Vitamin D and cardiovascular disease. Curr Med Chem. 2006;13(20):2443–7. Review.
• Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005 Oct;94(4):483–92. Review.
• Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):188–97.
• Secondary hyperparathyroidism promotes the acute phase response — a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses. 2005;64(5):1022–6.
• New light shines on old "vitamin". Vitamin D's influence extends beyond bone to blood pressure and heart disease. Harv Heart Lett. 2004 Sep;15(1):5.
• Candidate foods in the Asia-Pacific region for cardiovascular protection: fish, fruit and vegetables. Asia Pac J Clin Nutr. 2001;10(2):134–7. Review.
• Respiratory infection and coronary heart disease: progression of a paradigm. QJM. 2000 Jun;93(6):375–83.
• Are there gender differences regarding coronary artery calcification. Am J Card Imaging. 1996 Jan;10(1):72–7. Review.
• Diet of Finnish children in relation to the family's socio-economic status. Scand J Soc Med. 1995 Jun;23(2):88–94.
• Nutrition in the prevention of ischemic heart disease. Bratisl Lek Listy. 1989 Mar;90(3):203–21.
• Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol. 1981 Dec;10(4):337–41.
• Congenital heart disease in Nigeria: a ten-year experience at UCH, Ibadan. Ann Trop Paediatr. 1981 Jun;1(2):77–85.

Chronic Kidney Disease-related Mortality

• The association of adiposity with parathyroid hormone in healthy older adults. Endocrine. 2009 Oct;36(2):218–23.
• Pin1 regulates parathyroid hormone mRNA stability. J Clin Invest. 2009 Oct;119(10):2887–91.
• Secondary hyperparathyroidism: pathophysiology and treatment. J Am Board Fam Med. 2009 Sep–Oct;22(5):574–81.
• Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol. BMC Nephrol. 2009 Sep 24;10(1):28.
• Treating mineral metabolism disorders in patients undergoing long hemodialysis: A search for an optimal strategy. Hemodial Int. 2009 Sep 16.
• Statins and vitamin D: a friendly association in pre-dialysis patients. Int Urol Nephrol. 2009 Sep 11.
• Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol. 2009 Sep;4(9):1529–39.
• Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009 Aug 5.
• Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol. 2009 Jun;4(6):1128–35.
• The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. Eur J Pharmacol. 2009 May 24.
• Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009 May 19;119(19):2545–52.
• Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder? Curr Opin Nephrol Hypertens. 2009 May 19.
• Klotho Variants and Chronic Hemodialysis Mortality. J Bone Miner Res. 2009 May 6.
• Chronic kidney disease (CKD) and bone. Control of CKD-MBD from the viewpoint of the medical cost. Clin Calcium. 2009 Apr;19(4):529–36.
• Update on the treatment of chronic kidney disease-mineral and bone disorder. J Ren Care. 2009 Mar;35 Suppl 1:19–27.
• The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2009 Mar;24(3):963–72.
• Mortality reduction by vitamin D receptor activation in end-stage renal disease: a commentary on the robustness of current data. Nephrol Dial Transplant. 2009 Mar;24(3):703–6.
• Role of vitamin D in chronic kidney disease. Semin Nephrol. 2009 Mar;29(2):113–21.
• Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions. Semin Nephrol. 2009 Mar;29(2):105–12.
• 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant. 2009 Feb;24(2):611–8.
• Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis. Pharmacotherapy. 2009 Feb;29(2):154–64.
• Low Plasma Level of Cathelicidin Antimicrobial Peptide (hCAP18) Predicts Increased Infectious Disease Mortality in Patients Undergoing Hemodialysis. Clin Infect Dis. 2009 Jan 9.
• Vitamin D levels and their relationship with cardiac biomarkers in chronic hemodialysis patients. J Korean Med Sci. 2009 Jan;24 Suppl:S109–14.
• Klotho gene, phosphocalcic metabolism, and survival in dialysis. J Ren Nutr. 2009 Jan;19(1):50–6. Review.
• Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009 Jan;75(1):88–95.
• New Acquisitions in Therapy of Secondary Hyperparathyroidism in Chronic Kidney Disease and Peritoneal Dialysis Patients: Role of Vitamin D Receptor Activators. Contrib Nephrol. 2009;163:219–226.
• Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease. Blood Purif. 2009;27(4):350–9.
• Vitamin D use and mortality in chronic kidney disease: immortal time bias. Arch Intern Med. 2008 Nov 24;168(21):2384–5; author reply 2385–6.
• Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2008 Nov;3(6):1769–76.
• Vitamin D and glucose metabolism in chronic kidney disease. Curr Opin Nephrol Hypertens. 2008 Nov;17(6):566–72. Review.
• 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol—an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Dan Med Bull. 2008 Nov;55(4):186–210. Review.
• Vitamin D treatment in chronic kidney disease: what we really need to know. Arch Intern Med. 2008 Oct 13;168(18):2045; author reply 2046.
• Vitamin D therapy and reduced mortality in chronic kidney disease. Arch Intern Med. 2008 Oct 13;168(18):2045–6; author reply 2046.
• Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008 Oct;52(4):661–71.
• Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int. 2008 Oct;74(8):1070–8.
• Vitamin D and kidney disease. Clin J Am Soc Nephrol. 2008 Sep;3(5):1555–60.
• Endothelial dysfunction and chronic kidney disease: treatment options. Curr Opin Investig Drugs. 2008 Sep;9(9):970–82.
• Does treatment with calcitriol improve survival in predialysis patients with chronic kidney disease? Nat Clin Pract Endocrinol Metab. 2008 Sep;4(9):484–5.
• Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension. 2008 Aug;52(2):249–55.
• Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol. 2008 Aug;19(8):1613–9.
• Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2008 Aug;74(3):389; author reply 389.
• Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol. 2008 Jul;19(7):1379–88.
• Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int. 2008 Jun;73(12):1355–63. Review.
• Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int. 2008 Jun;28 Suppl 3:S183–7. Review.
• Iron indices and vitamin D receptor polymorphisms in hemodialysis patients. Adv Chronic Kidney Dis. 2008 Apr;15(2):186–90.
• Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease. Clin Exp Nephrol. 2008 Apr;12(2):126–31.
• New approaches to treatment of secondary hyperparathyroidism. Curr Opin Investig Drugs. 2008 Apr;9(4):363–70. Review.
• Improved patient outcomes in chronic kidney disease: optimizing vitamin D therapy. Nephrol Nurs J. 2008 Mar–Apr;35(2 Suppl):5S–22S; quiz 23S. Review.
• Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med. 2008 Feb 25;168(4):397–403.
• Vitamin D receptor alleles and C-reactive protein in hemodialysis patients. Ital J Anat Embryol. 2008 Jan–Mar;113(1):55–62.
• Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Endocr Pract. 2008 Jan–Feb;14(1):18–27. Review.
• Bone and mineral guidelines for patients with chronic kidney disease: a call for revision. Clin J Am Soc Nephrol. 2008 Jan;3(1):179–83. Review.
• Battleground: chronic kidney disorders mineral and bone disease—calcium obsession, vitamin d, and binder confusion. Clin J Am Soc Nephrol. 2008 Jan;3(1):168–73. Review.
• Diagnostic procedures and rationale for specific therapies in chronic kidney disease-mineral and bone disorder. Contrib Nephrol. 2008;161:222–33. Review.
• Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Intern Med. 2008;47(11):989–94. Review.
• Changes in the prognosis for survival of patients with end-stage renal disease (ESRD) treated by hemodialysis. Nippon Jinzo Gakkai Shi. 2008;50(2):127–34.
• Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med. 2007 Dec 18;147(12):840–53.
• Parathyroid and bone. Mineral and bone disorder and parathyroid function in chronic kidney disease. Clin Calcium. 2007 Dec;17(12):1870–8. Review.
• CKD-MBD: impact on management of kidney disease. Clin Exp Nephrol. 2007 Dec;11(4):261–8. Review.
• Vitamin D, cardiovascular disease, and survival in dialysis patients. J Bone Miner Res. 2007 Dec;22 Suppl 2:V95–9. Review.
• Role of vitamin D deficiency in chronic kidney disease. J Bone Miner Res. 2007 Dec;22 Suppl 2:V91–4. Review.
• Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: the need for randomized trials. Kidney Int. 2007 Oct;72(8):909–11.
• Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int. 2007 Oct;72(7):895; author reply 895–6.
• Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007 Oct;72(8):1004–13.
• Vascular calcification and arterial stiffness in chronic kidney disease: implications and management. Nephrology (Carlton). 2007 Oct;12(5):500–9. Review.
• Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism. Ther Apher Dial. 2007 Oct;11 Suppl 1:S44–7.
• Mineral metabolism disturbances in patients with chronic kidney disease. Eur J Clin Invest. 2007 Aug;37(8):607–22. Review.
• Vitamin D receptor: a highly versatile nuclear receptor. Kidney Int. 2007 Aug;72(3):237–9.
• Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial. 2007 Jul–Aug;20(4):309–15. Review.
• Mineral-bone disorder with chronic kidney disease. Vnitr Lek. 2007 Jul–Aug;53(7–8):841–51. Review.
• 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007 Jul;50(1):69–77.
• Vascular calcification in dialysis patients. Prilozi. 2007 Jul;28(1):215–24. Review.
• New perspectives in the management of secondary hyperparathyroidism. Mini Rev Med Chem. 2007 Jun;7(6):591–8. Review.
• New Active vitamin D analogs and calcimimetics to control hyperparathyroidism in chronic renal failure. Clin Calcium. 2007 May;17(5):767–71. Review.
• Effects of vitamin D on non-classical target organs and survival. Clin Calcium. 2007 May;17(5):691–7. Review.
• Osteodystrophy and dialysis survival. Kidney Int. 2007 May;71(9):953; author reply 953–4.
• Vascular calcification in chronic kidney failure: role of vitamin D receptor. Curr Opin Investig Drugs. 2007 Mar;8(3):237–47. Review.
• Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):487–90. Review.
• Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant. 2007 Feb;22(2):515–21.
• Mechanisms of vascular calcification. Adv Chronic Kidney Dis. 2007 Jan;14(1):54–66. Review.
• Bone health in chronic kidney disease-mineral and bone disease. Adv Chronic Kidney Dis. 2007 Jan;14(1):27–36. Review.
• Vitamin D in patients with kidney disease: cautiously optimistic. Adv Chronic Kidney Dis. 2007 Jan;14(1):22–6. Review.
• Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis. 2007 Jan;14(1):3–12. Review.
• Multidisciplinary approach for prescriptive management of mineral and bone metabolism in chronic kidney disease: development of a dietetic led protocol. J Ren Care. 2006 Oct–Dec;32(4):187–91.
• Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. J Nephrol. 2006 Sep–Oct;19(5):566–77. Review.
• Vitamin D metabolism and chronic kidney disease. Clin Calcium. 2006 Jul;16(7):1143–46. Review.
• Renal osteodystrophy in children: a systemic disease associated with cardiovascular manifestations. Growth Horm IGF Res. 2006 Jul;16 Suppl A:S79–83. Review.
• Nephrology referral and appropriateness of therapeutic drug care in chronic kidney disease. J Nephrol. 2006 May–Jun;19(3):303–11.
• Cardiovascular disease in chronic kidney failure: the role of VDR activators. Curr Opin Investig Drugs. 2006 Mar;7(3):206–13. Review.
• Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006 Jan;69(1):33–43. Review.
• Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005 Nov;68(5):1973–81. Review.
• Vitamin D treatment in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):315–21. Review.
• The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl. 2005 Jun;(95):S37–42. Review.
• Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol. 2005 Apr;16(4):1115–25.
• Cardiovascular calcification and accelerated atherosclerosis in chronic kidney disease. Ital Heart J Suppl. 2005 Jan;6(1):25–8. Review.
• Pathogenesis of parathyroid hyperplasia in renal failure. J Nephrol. 2005 Jan–Feb;18(1):5–8.
• Vitamin D and survival of hemodialysis patients. Clin Calcium. 2004 Sep;14(9):64–8. Review.
• Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: another form of metabolic syndrome. Semin Nephrol. 2004 Sep;24(5):423–5. Review.
• 1 alpha-hydroxy vitamin D3 and cardiovascular mortality. Nephrol Dial Transplant. 2004 Jun;19(6):1660–1; author reply 1661.
• 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure. J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):507–11. Review.
• Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant. 2004 Jan;19(1):179–84.
• Vitamin D receptor and analogs. Semin Nephrol. 2004 Jan;24(1):10–6. Review.
• Hyperparathyroidism and long-term bone loss after renal transplantation. Clin Transplant. 2003 Jun;17(3):268–74.
• Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial. 2003 Mar–Apr;16(2):140–7.
• Endocrine abnormalities in chronic renal failure. Endocrinol Metab Clin North Am. 2002 Mar;31(1):107–19. Review.
• Is vitamin D receptor gene polymorphism an independent predictor of mortality in hemodialysis patients? Am J Kidney Dis. 2002 Feb;39(2):441–2.
• Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients. Am J Kidney Dis. 2001 Nov;38(5):965–74.
• Vitamin D deficiency is implicated in reduced serum albumin concentrations in patients with end-stage renal disease. Am J Kidney Dis. 2000 Aug;36(2):337–44.
• Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 1999 Aug;56(2):383–92. Review.
• Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron. 1997;77(1):37–43.
• Effects of secondary hyperparathyroidism on cardiac function in pediatric patients on hemodialysis. Turk J Pediatr. 1995 Oct–Dec;37(4):299–304.

Colonic Injury-related Mortality

• Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 2007 Mar 30;8:5.

COPD-related Mortality

• Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr. 2008 Feb;87(2):385–90.
• The effects of air pollution on the health of children. Paediatr Child Health. 2006 Oct;11(8):513–6.

Diabetes-related Mortality

• Vitamin D deficiency and the risk of incident Type 2 diabetes. Future Cardiol. 2009 Jan;5(1):15–8.
• Vitamin D and diabetes: let the sunshine in. Diabetes Educ. 2008 Nov–Dec;34(6):939–40, 942, 944 passim. Review.

Epilepsy-related Mortality

• Increased severity of chemically induced seizures in mice with partially deleted Vitamin D receptor gene. Neurosci Lett. 2006 Feb 6;394(1):69–73.
• Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res Bull. 2005 Sep 30;67(1–2):156–60.

Infectious Pathogen-related Mortality

• Perinatal Outcomes, Including Mother-to-Child Transmission of HIV, and Child Mortality and Their Association with Maternal Vitamin D Status in Tanzania. J Infect Dis. 2009 Oct 1;200(7):1022–30.
• Human genes in TB infection: their role in immune response. Monaldi Arch Chest Dis. 2008 Mar;69(1):24–31. Review.
• On the epidemiology of influenza. Virol J. 2008 Feb 25;5:29. Review.
• Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008 Feb;4(2):80–90. Review.
• Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab. 2007;51(4):301–23. Review.
• A potential role for vitamin D on HIV infection? Nutr Rev. 2006 May;64(5 Pt 1):226–33. Review.
• Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg. 2002 Jul;67(1):102–6.
• Seasonality of tuberculosis: the reverse of other respiratory diseases in the UK. Thorax. 1996 Sep;51(9):944–6.
• Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D. J Infect Dis. 1996 Jan;173(1):259–62.
• Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J Infect Dis. 1994 Apr;169(4):889–93.

Inflammatory Bowel Disease-related Mortality

• A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 2003 Dec;17(12):2386–92.
• Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system. Arch Biochem Biophys. 2002 Jun 15;402(2):249–54.

Liver Disease-related Mortality

• Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. Semin Thromb Hemost. 2007 Nov;33(8):798–809. Review.
• Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis. Liver Transpl. 2007 Sep;13(9):1254–61.
• Gc-globulin and prognosis in acute liver failure. Liver Transpl. 2005 Oct;11(10):1223–7.
• Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology. 1995 Jan;21(1):101–5.
• Proportion of circulating Gc (vitamin D-binding protein) in complexed form: relation to clinical outcome in fulminant hepatic necrosis. Gastroenterology. 1988 Jun;94(6):1454–8.

Osteomalacia-related Mortality

• Osteomalacia with fatal outcome in an elderly patient. Dtsch Med Wochenschr. 2003 Dec 12;128(50):2644–6.
• Osteomalacia in Algeria. How to improve fetal and maternal mortality without medical manpower. Am J Obstet Gynecol. 1968 Nov 1;102(5):749–51.

Osteoporosis-related Mortality

• Elevated Serum PTH Is Independently Associated with Poor Outcomes in Older Patients with Hip Fracture and Vitamin D Inadequacy. Calcif Tissue Int. 2009 Sep 11.
• Austrian osteoporosis report: epidemiology, lifestyle factors, public health strategies. Wien Med Wochenschr. 2009 May;159(9–10):221–229.
• Diagnosis and management of osteoporosis. Prim Care. 2009 Mar;36(1):181–98, x.
• The Frequency of Osteoporosis Screening in Men With Inflammatory Bowel Disease. Am J Mens Health. 2009 Feb 2.
• Diagnosis and treatment of osteoporosis. Am Fam Physician. 2009 Feb 1;79(3):193–200. Review.
• Compliance with osteoporosis treatment guidelines in postmenopausal women. Ann Pharmacother. 2009 Feb;43(2):242–50.
• Screening for osteoporosis: a survey of older psychiatric inpatients at a tertiary referral centre. Int Psychogeriatr. 2009 Feb;21(1):180–6.
• Prevention and treatment of senile osteoporosis and hip fractures. Minerva Med. 2009 Feb;100(1):79–94.
• Outcome of osteoporotic pelvic fractures: an underestimated severity. Survey of 60 cases. Joint Bone Spine. 2008 Oct;75(5):585–8.
• The use of calcium and vitamin D in the management of osteoporosis. Ther Clin Risk Manag. 2008 Aug;4(4):827–36.
• Osteoporotic fractures: a brain or bone disease? Curr Osteoporos Rep. 2008 Jun;6(2):57–61.
• Osteoporosis in men. Endocr Rev. 2008 Jun;29(4):441–64. Review.
• Prevention and treatment of postmenopausal osteoporosis. Obstet Gynecol Clin North Am. 2008 Jun;35(2):301–15, ix. Review.
• Osteoporotic fractures: a brain or bone disease? Curr Osteoporos Rep. 2008 Jun;6(2):57–61.
• Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system. Clin Calcium. 2008 May;18(5):677–84. Review.
• Osteoporosis and its implications for dental patients. J Am Dent Assoc. 2008 May;139(5):545–52; quiz 625–6. Review.
• Pathogenesis, diagnosis and treatment of osteoporosis in men. Pol Merkur Lekarski. 2008 Jan;24(139):76–80. Review.
• Growth and bone development. Nestle Nutr Workshop Ser Pediatr Program. 2008;61:53–68. Review.
• Survival and functional outcome according to hip fracture type: a one-year prospective cohort study in elderly women with an intertrochanteric or femoral neck fracture. Bone. 2007 Dec;41(6):958–64.
• Secondary prevention of osteoporosis: Calcium, Vitamin D and bisphosphonate prescribing following distal radial fracture. Injury. 2007 Nov;38(11):1236–40.
• Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007 Nov 1;357(18):1799–809.
• Assessment of endocrine and nutritional status in age-related catabolic states of muscle and bone. Curr Opin Clin Nutr Metab Care. 2007 Sep;10(5):604–10. Review.
• Rehabilitation of elderly patients after fracture. Rev Med Suisse. 2007 Jun 13;3(115):1512–4. Review.
• Older patients with hip fractures: evaluation of a long-term specialist orthopaedic medicine service in their outcomes. N Z Med J. 2007 May 18;120(1254):U2535.
• Vascular calcification and osteoporosis—from clinical observation towards molecular understanding. Osteoporos Int. 2007 Mar;18(3):251–9. Review.
• Falls—where do we stand? Mo Med. 2007 Jan–Feb;104(1):63–7. Review.
• Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab. 2006 Aug;91(8):2980–5.
• Osteoporosis in men. J Am Acad Orthop Surg. 2006 Jun;14(6):347–53. Review.
• Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc. 2006 May;81(5):662–72. Review.
• Osteoporosis and skeletal fractures. HSS J. 2006 Feb;2(1):62–9.
• Osteoporosis in men: prevalence and investigation. Clin Cornerstone. 2006;8 Suppl 3:S20–5. Review.
• Vitamin D insufficiency in male osteoporosis. Clin Cornerstone. 2006;8 Suppl 3:S14–9.
• Developmental origins of osteoporotic fracture: the role of maternal vitamin D insufficiency. J Nutr. 2005 Nov;135(11):2728S–34S.
• Nutritional treatment of bone fracture. Curr Opin Clin Nutr Metab Care. 2005 Jul;8(4):377–81. Review.
• Shared care between geriatricians and orthopaedic surgeons as a model of care for older patients with hip fractures. N Z Med J. 2005 May 6;118(1214):U1438.
• Male osteoporosis: new trends in diagnosis and therapy. Drugs Aging. 2005;22(9):741–8. Review.
• Bone mineral density, carotid artery intimal medial thickness, and the vitamin D receptor BsmI polymorphism in Mexican American women. Calcif Tissue Int. 2004 Oct;75(4):292–8.
• Effect of Vitamin D on falls: a meta-analysis. JAMA. 2004 Apr 28;291(16):1999–2006. Review.
• Prevention of hip fractures: medical and nonmedical management. Instr Course Lect. 2004;53:417–25. Review.
• Clinical pharmacology of old age syndromes. Br J Clin Pharmacol. 2003 Sep;56(3):261–72. Review.
• Osteoporosis and cardiovascular disease—two sides of the same coin? Med Klin (Munich). 2003 Aug 15;98(8):437–46. Review.
• Osteoporosis in men. Am Fam Physician. 2003 Apr 1;67(7):1521–6. Review.
• Role of vascular factors in osteoporosis. J Gerontol A Biol Sci Med Sci. 2003 Apr;58(4):362–6. Review.
• Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003 Mar 1;326(7387):469.
• How to prevent fractures in the individual with osteoporosis. Best Pract Res Clin Rheumatol. 2001 Jul;15(3):497–515. Review.
• Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr. 2001 Apr;4(2B):547–59. Review.
• Osteoporosis: a factor in mortality following cardiac surgery. Conn Med. 2000 Feb;64(2):71–3.
• Osteoporosis management. Int J Fertil Womens Med. 1999 Sep–Oct;44(5):241–9. Review.
• Managing elderly people's osteoporosis. Why? Who? How? Can Fam Physician. 1999 Jun;45:1526–36.
• Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men. Int J Androl. 1997 Jun;20(3):134–43. Review.
• Calcium and vitamin D nutritional needs of elderly women. J Nutr. 1996 Apr;126(4 Suppl):1165S–7S.
• Effect of ozone variation on disease in Great Britain: II. Femoral neck fracture. Aviat Space Environ Med. 1978 Aug;49(8):1014–8.
• Deaths from falls and fractures. Comparison of mortality in Scotland and the United States with that in England and Wales. Br J Prev Soc Med. 1973 Nov;27(4):247–54.

Preeclampsia and Eclampsia Mortality

• The role of nutritional factors in pre-eclampsia and eclampsia. Srp Arh Celok Lek. 1996 May–Jun;124(5–6):156–9.
• On safe motherhood. Nurs J India. 1988 May;79(5):119–20, 128.

Rickets-related Mortality

• Nutritional bone disease in Indian population. Indian J Med Res. 2008 Mar;127(3):219–28. Review.
• Rickets in the 17th century. J Bone Miner Res. 2006 Oct;21(10):1506–10. Review.
• Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet. 1997 Jun 21;349(9068):1801–4.
• 2 cases of death due to rickets. Dtsch Med Wochenschr. 1964 Aug 7;89:1497–500.

Sepsis Mortality

• High C5a levels are associated with increased mortality in sepsis patients—no enhancing effect by actin-free Gc-globulin. Clin Biochem. 2008 Aug;41(12):974–80.
• Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit Care Med. 2003 Jan;31(1):152–6.
• Alterations in Gc levels and complexing in septic shock. Circ Shock. 1989 Jul;28(3):249–55.
• The multifactorial basis for hypocalcemia during sepsis. Studies of the parathyroid hormone-vitamin D axis. Ann Intern Med. 1987 Jul;107(1):36–41.

Toxin-related Mortality

• Mortality in a cohort of licensed pesticide applicators in Florida. Occup Environ Med. 1999 Jan;56(1):14–21.
• Studies on health effects of cadmium exposure in the general environment. Nippon Eiseigaku Zasshi. 1995 Feb;49(6):960–72. Review.
• Aluminum:related bone disease. Blood Purif. 1988;6(1):1–15.
• Interrelationships of mycotoxins with nutrition. Fed Proc. 1977 May;36(6):1899–902. Review.

Transplant-related Mortality

• Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. Bone Marrow Transplant. 2002 Aug;30(4):223–8.
• In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). Arch Biochem Biophys. 2000 May 1;377(1):135–8.

Trauma-related Mortality

• Trauma stimulates the synthesis of Gc-globulin. Intensive Care Med. 2001 Feb;27(2):394–9.
• Admission level of Gc-globulin predicts outcome after multiple trauma. Injury. 1999 May;30(4):275–81.
• Serum Gc-globulin in the early course of multiple trauma. Crit Care Med. 1998 Feb;26(2):285–9.

back to research menu